What is in the Mod GRF 1-29 & GHRP-2 blend?
This vial combines two research peptides that act on different receptors involved in growth hormone release, with 10mg of peptide in total.
- Mod GRF 1-29 (CJC-1295 without DAC): GHRH(1-29) with four amino-acid substitutions, which acts on the GHRH receptor.
- GHRP-2 (pralmorelin): a synthetic hexapeptide that acts on the ghrelin (GHS) receptor.
Mod GRF 1-29 & GHRP-2 vs CJC-1295 & GHRP-2
This blend always contains CJC-1295 without DAC (Mod GRF 1-29), which has no albumin-binding linker and is cleared within minutes to hours. Our CJC-1295 & GHRP-2 Blend is listed under the general name “CJC-1295”, which can also mean the longer-acting form with DAC (a drug affinity complex that binds albumin and extends half-life to several days). The GHRP-2 part and the 10mg total are the same. Ask us which form a batch contains if you are comparing the two.
Regulatory status
Neither peptide is an approved medicine in its research form. GHRH analogues and growth hormone-releasing peptides are prohibited at all times in competitive sport by the World Anti-Doping Agency. This product is sold for laboratory research use only.
Related products
- Each peptide on its own: Mod GRF 1-29 and GHRP-2.
- Other Mod GRF 1-29 combinations: with GHRP-6 and with ipamorelin.
- Also available: Sermorelin & GHRP-2 Blend.
Handling and research-use notice
Store and handle this material as stated on the label and certificate of analysis for your batch; see our guide to storing research peptides. This product is sold for laboratory research use only. It is not a medicine or supplement and is not for human or veterinary use.
